Treatment of actinomyces naeslundii-related diseases with exogenous lactic bacteria strains
US7491386B2 · kind B2 · utility
11Cited by
14References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2004 |
| Grant date | Feb 17, 2009 |
| Priority date | — |
| Expiry date | Jan 16, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/885
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A lactic bacteria strain that is exogenous to the oral microflora is selected for its ability to adhere the pellicle of the teeth and to produce a growth inhibition factor. This strain is used for the preparation of a composition intended for reducing dental plaque and for treating or preventing root caries and other diseases related to Actinomyces naeslundii in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.